Skip to content
Open Data Finder
Open Government Canada

Guidance for market authorization requirements for COVID-19 drugs: Overview

Published by Health Canada | Santé Canada

About this dataset

This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.

Guidance for market authorization requirements for COVID-19 drugs: Overview · Open Data Finder